Recombinant CCR5 (Leronlimab Biosimilar) antibody (PE)

Catalog No. ABIN7867131

The Humanized Monoclonal anti-CCR5 (Leronlimab Biosimilar) antibody is suitable to detect CCR5 (Leronlimab Biosimilar) in samples from Human. It has been validated for FACS.

Quick Overview for Recombinant CCR5 (Leronlimab Biosimilar) antibody (PE) (ABIN7867131)

Target: CCR5 (Leronlimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CCR5 (Leronlimab Biosimilar) antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Product Details anti-CCR5 (Leronlimab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-CCR5(leronlimab biosimilar) mAb

Isotype: IgG4, P108S

Application Details

Application Notes: Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid PBS with 0.05 %  Proclin300, 1 % BSA

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment:  Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for CCR5 (Leronlimab Biosimilar)

Target: CCR5 (Leronlimab Biosimilar)

Alternative Name: leronlimab biosimilar

Target Type: Biosimilar

Background:

Synonyms: CKR5, CCR-5, CD195, CKR-5, CCCKR5, CMKBR5, IDDM22, CC-CKR-5,PRO 140, HuPRO-140, PRO-140

Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

UniProt: P51681